Lung Cancer Update cover image

Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?

Lung Cancer Update

00:00

Is TDXD in Lung Cancer?

In breast cancer, they're a lot more exquisite in terms of chemo sensitivity. So 5.4 dose was pursued because some investigators and the drug developers thought that you don't need too much dosing for breasts. And there's a no pain, no game kind of concept. But evidently, the Destiny Lung O2 had proven that that 5.4 is just as good and less toxic. It's not exactly the same. A lot of my patients on in the early days of drug development have been dose reduced to 4.4 and they're still responding today.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app